These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24557998)

  • 1. [Anemia and hemoglobin diseases in patients with migration background].
    Eber S; Dickerhoff R
    Dtsch Med Wochenschr; 2014 Feb; 139(9):434-40. PubMed ID: 24557998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of alpha-thalassemia and homozygous sickle-cell disease.
    Higgs DR; Aldridge BE; Lamb J; Clegg JB; Weatherall DJ; Hayes RJ; Grandison Y; Lowrie Y; Mason KP; Serjeant BE; Serjeant GR
    N Engl J Med; 1982 Jun; 306(24):1441-6. PubMed ID: 6176865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia.
    Powars DR; Schroeder WA; Weiss JN; Chan LS; Azen SP
    J Clin Invest; 1980 Mar; 65(3):732-40. PubMed ID: 6153392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
    Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
    J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of thalassemia and sickle cell anemia in children].
    Girot R
    Ann Pediatr (Paris); 1978; 25(5-6):277-84. PubMed ID: 16114336
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sickle cell disease in Germany -- disease manifestations, therapeutic options and possibilities for improvement of care].
    Dickerhoff R
    Klin Padiatr; 2006; 218(3):165-9. PubMed ID: 16688673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential diagnostic criteria in hemoglobinosis S/beta-thalassemia].
    Kolodeĭ SV
    Probl Gematol Pereliv Krovi; 1979 Nov; 24(11):11-5. PubMed ID: 504091
    [No Abstract]   [Full Text] [Related]  

  • 8. Sickle cell syndromes. I. Hemoglobin SC-alpha-thalassemia.
    Honig GR; Gunay U; Mason RG; Vida LN; Ferenc C
    Pediatr Res; 1976 Jun; 10(6):613-20. PubMed ID: 1272638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain in sickle cell disease. Rates and risk factors.
    Platt OS; Thorington BD; Brambilla DJ; Milner PF; Rosse WF; Vichinsky E; Kinney TR
    N Engl J Med; 1991 Jul; 325(1):11-6. PubMed ID: 1710777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease.
    Manfrè L; Giarratano E; Maggio A; Banco A; Vaccaro G; Lagalla R
    AJR Am J Roentgenol; 1999 Dec; 173(6):1477-80. PubMed ID: 10584785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red cell distribution width in sickle cell disease.
    Webster P; Castro O
    Ann Clin Lab Sci; 1986; 16(4):274-7. PubMed ID: 3740796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle-delta beta thalassemia: mild sickling disorder with serious morbidity in pregnancy.
    Cohen AW; Russell MO; Mennuti MT
    Obstet Gynecol; 1981 Jul; 58(1):127-30. PubMed ID: 7243140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.
    Mokhtar GM; Adly AA; El Alfy MS; Tawfik LM; Khairy AT
    Hemoglobin; 2010; 34(1):78-94. PubMed ID: 20113292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.
    Embury SH; Dozy AM; Miller J; Davis JR; Kleman KM; Preisler H; Vichinsky E; Lande WN; Lubin BH; Kan YW; Mentzer WC
    N Engl J Med; 1982 Feb; 306(5):270-4. PubMed ID: 6172710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatographic measurements of hemoglobin A2 in blood samples that contain sickle hemoglobin.
    Shokrani M; Terrell F; Turner EA; Aguinaga MD
    Ann Clin Lab Sci; 2000 Apr; 30(2):191-4. PubMed ID: 10807164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies.
    Sher GD; Ginder GD; Little J; Yang S; Dover GJ; Olivieri NF
    N Engl J Med; 1995 Jun; 332(24):1606-10. PubMed ID: 7753139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What determines severity in sickle-cell disease?
    Schechter AN; Bunn HF
    N Engl J Med; 1982 Feb; 306(5):295-7. PubMed ID: 6172711
    [No Abstract]   [Full Text] [Related]  

  • 19. Mortality in sickle cell disease. Life expectancy and risk factors for early death.
    Platt OS; Brambilla DJ; Rosse WF; Milner PF; Castro O; Steinberg MH; Klug PP
    N Engl J Med; 1994 Jun; 330(23):1639-44. PubMed ID: 7993409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical, hematological and molecular findings of Jamaican and Sicilian patients with sickle cell disease.
    Schiliro G; Russo Mancuso G; Kulozik AE; Serjeant BE; Serjeant GR
    Haematologica; 1990; 75 Suppl 5():42-56. PubMed ID: 2086381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.